室性心律失常临床治疗体会

The ventricular arrhythmias clinical experience

目的分析探讨室性心律失常应用胺碘酮联合美托洛尔进行治疗的临床疗效以及安全性情况。方法选取从2011年2月至2012年7月在本院治疗的100例室性心律的患者作为研究对象,按照随机平均原则分成对照组与治疗组,各50例。对照组在一般综合治疗的基础上用胺碘酮进行治疗;治疗组则在对照组的基础上加用美托洛尔。观察治疗后两组患者的总有效率、不良反应等情况。结果治疗后对照组与治疗组患者心率控制的总有效率、不良反应发生率分别为96%、4%、和72%、16%,经χ2检验比较两组总有效率、不良反应发生率的差异均有统计学意义(P<O.05)。结论胺碘酮联合美托洛尔治疗室性心律失常的临床疗效比单独用胺碘酮的临床疗效显著,不良反应发生少,是一种安全高效的治疗方法,值得临床推广应用。

Objective To analyze the clinical efficacy and security explore ventricular arrhythmias amiodarone plus metoprolol treatment. Methods Select From February 2011 to July 2012 in our hospital,100 cases of ventricular arrhythmia patients were selected as research subjects,divided into a control group and the treatment group,50 patients according to the random principle. Control group on the basis of general treatment with amiodarone treatment; treatment group was added in the control group on the basis of metoprolol. Observe After treatment,the total efficiency,adverse reactions. Results After treatment,the control group and the treatment group heart rate control in patients with total efficiency,the incidence of adverse reactions were 96%,4%, and 72%,16%,total efficiency,the incidence of adverse reactions in the two groups were compared by the χ2 test the differences were statistically significant （P 0. 05） . Conclusion The clinical efficacy of amiodarone metoprolol treatment of ventricular arrhythmias than the clinical efficacy of amiodarone alone significantly,the incidence of adverse reactions,is a safe and effective treatment,worthy of clinical application.